e-ISSN: Pending

Browse the failure-mode index

2 real negative results, null findings, and replication failures in Medical physics. Medical radiology. Nuclear medicine · Failed Experiment Report. Search the index →

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record compiled from open scholarly databases; the abstract is shown in full only where the paper is openly licensed, otherwise a short excerpt under fair use. Classifications are automated and approximate.

Failed Experiment ReportOpen accessMedical physics. Medical radiology. Nuclear medicine

Value of renal resistive index in hepatitis C virus related liver cirrhosis and its response to midodrine

Sameh Ahmed Abdel-bary, Eslam Safwat, Hany Ali Hussein et al. · 2014 · The Egyptian Journal of Radiology and Nuclear Medicine

Background: Hyperdynamic circulatory state in liver cirrhosis is characterized by increased splanchnic blood flow and renal vasoconstriction. Aim: To evaluate the relationship between renal resistive indices (RI) and HCV liver cirrhosis severity and RI value in predicting 6 month survival of those patients. Also we aimed to assess the effect of midodrine on RI. Patients and methods: 120 patients with HCV liver cirrhosis and 40 healthy controls were enrolled in the study. INR, total bilirubin, albumin, creatinine and sodium were measured in all patients. Both patients and controls underwent abd

View details →
Failed Experiment ReportOpen accessMedical physics. Medical radiology. Nuclear medicine

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer

Ma Li, Men Yu, Feng Lingling et al. · 2019 · Radiology and Oncology

The mainstay therapy for locally advanced non-small cell lung cancer is concurrent chemoradiotherapy. Loco-regional recurrence constitutes the predominant failure patterns. Previous studies confirmed the relationship between increased biological equivalent doses and improved overall survival. However, the large randomized phase III study, RTOG 0617, failed to demonstrate the benefit of dose-escalation to 74 Gy compared with 60 Gy by simply increasing fraction numbers.

View details →